Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
Caribou cuts 32% of staff, further purges cell therapy pipeline
The cuts are Caribou's second in less than a year, following another layoff round and the shuttering of an NK cell therapy program in July 2024.
Darren Incorvaia
Apr 24, 2025 9:55pm
Evotec axes 30% of assets as cost-cutting push hits pipeline
Apr 17, 2025 9:45am
Cyclacel sheds clinical asset in effort to stop cash spiral
Apr 2, 2025 6:01pm
ImmuneOnco axes CD47 bispecific amid pipeline prioritization
Mar 26, 2025 6:21am
Adaptimmune questions own longevity, axes preclinical funding
Mar 20, 2025 2:04pm
Cell therapy biotech axes cancer trial, turns to autoimmune
Mar 19, 2025 5:35pm